German chemicals group Evonik Industries missed fourth-quarter core profit expectations on Thursday but reported a rise year-on-year and forecast further growth in 2022 even though it faces macroeconomic headwinds, said Reuters.
Evonik’s shares were down 2.6% as of 1420 GMT, after it reported adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of 502 million euros (USD556.77 million), 5% below analysts’ forecast of 526.6 million euros, but up 20% on the year.
“It is a difficult day for many chemicals producers,” Berenberg analyst Sebastian Bray said, also citing German peers Covestro and BASF, which were both trading down 3%. “The reason is macroeconomic worries – oil at USD115/barrel, labour cost inflation, some companies have missed estimates on margins squeeze from higher raw materials. This could indicate a more difficult operating environment than perhaps anticipated."
Evonik’s CEO Christian Kullmann, in reference to Russia’s invasion of Ukraine, told a press conference that the company’s energy supplies were secure as far as it could see, but was cautious of further prices increases. “Energy prices have already come to be a severe burden for our industry today. Another increase would now actually and clearly go beyond the threshold of pain,” he said.
Evonik made roughly 200 million euros in sales in Russia last year, just above 1% of the total figure, and Kullmann said it would continue the business to the extent possible. The Essen-based company forecast adjusted core profit to come in at 2.5 billion to 2.6 billion euros in 2022, above the 2021 figure of 2.38 billion euros. Adjusted core profit is expected to grow by at least 10% year-on-year in the first quarter.
As MRC reported before, Evonik is investing a three-digit million-euro sum in the construction of a new production plant for bio-based and fully biodegradable rhamnolipids. The decision to build the plant follows a breakthrough in Evonik's research and development. Rhamnolipids are biosurfactants and serve as active ingredients in shower gels and detergents. Demand for environ-mentally friendly surfactants is growing rapidly worldwide.
We remind that in February, 2020, Dow and Evonik entered into an exclusive technology partnership. Together, they plan to bring a unique method for directly synthesizing propylene glycol (PG) from propylene and hydrogen peroxide to market maturity.
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of EUR12.2 billion and an operating profit (adjusted EBITDA) of EUR1.91 billion in 2020. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: to improve life today and tomorrow.
MRC